Tesla
TSLA
Apple
AAPL
Meta Platforms
META
4
Microsoft
MSFT
5
Netflix
NFLX
US Stock MarketDetailed Quotes
INZY Inozyme Pharma
- 0.974
- +0.020+2.04%
Close Mar 21 16:00 ET
- 0.990
- +0.016+1.63%
Post 20:01 ET
62.58MMarket Cap-0.60P/E (TTM)
0.996High0.910Low627.12KVolume0.939Open0.955Pre Close600.29KTurnover1.75%Turnover RatioLossP/E (Static)64.24MShares7.79552wk High1.08P/B34.93MFloat Cap0.91052wk Low--Dividend TTM35.86MShs Float31.650Historical High--Div YieldTTM9.04%Amplitude0.910Historical Low0.957Avg Price1Lot Size
Inozyme Pharma Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -30.04%-91.91M | -3.79%-19.19M | -30.00%-24.53M | -52.16%-23.66M | -38.04%-24.53M | -22.36%-70.68M | -28.38%-18.49M | -30.00%-18.87M | -5.86%-15.55M | -25.51%-17.77M |
| Net income from continuing operations | -43.35%-102.02M | -25.67%-27.07M | -47.67%-24.57M | -73.48%-27.03M | -34.15%-23.35M | -6.13%-71.17M | -16.18%-21.54M | -1.62%-16.64M | -2.11%-15.58M | -3.08%-17.4M |
| Operating gains losses | ---- | ---- | ---- | ---- | ---- | 17.65%20K | ---- | ---- | ---- | ---- |
| Depreciation and amortization | -10.92%742K | -15.31%177K | -6.25%195K | -10.05%188K | -12.08%182K | 11.96%833K | 5.56%209K | 10.05%208K | 16.76%209K | 16.29%207K |
| Other non cash items | 56.14%1.76M | 39.22%465K | 45.05%454K | 56.79%439K | 101.52%397K | 113.69%1.12M | 85.56%334K | 128.47%313K | 164.15%280K | 91.26%197K |
| Change In working capital | 252.95%4.71M | 98.80%5.82M | 34.67%-1.92M | 327.26%2.16M | 36.73%-1.34M | -253.18%-3.08M | 19.10%2.93M | -1,751.12%-2.94M | 31.61%-950K | -376.14%-2.12M |
| -Change in prepaid assets | 145.42%917K | 79.15%1.35M | 69.38%-890K | -317.24%-726K | 283.17%1.18M | -421.71%-2.02M | -20.49%753K | -31.78%-2.91M | -132.10%-174K | -6.36%309K |
| -Change in payables and accrued expense | 3,926.83%4.71M | 97.23%4.7M | -563.01%-801K | 689.02%3.11M | -7.06%-2.3M | -104.09%-123K | 51.37%2.38M | -93.20%173K | 69.39%-528K | -450.49%-2.15M |
| -Change in other current liabilities | 3.19%-910K | -11.32%-236K | -11.71%-229K | 9.27%-225K | 20.00%-220K | -54.61%-940K | -221.21%-212K | -11.41%-205K | -37.02%-248K | -55.37%-275K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -30.04%-91.91M | -3.79%-19.19M | -30.00%-24.53M | -52.16%-23.66M | -38.04%-24.53M | -22.36%-70.68M | -28.38%-18.49M | -30.00%-18.87M | -5.86%-15.55M | -25.51%-17.77M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 224.89%67M | 338.64%15.44M | 152.33%23.35M | 209.12%17.82M | -24.50%10.39M | -892.89%-53.65M | -301.06%-6.47M | -440.33%-44.62M | 28.78%-16.33M | -38.99%13.77M |
| Net PPE purchase and sale | 79.19%-62K | 83.81%-17K | -85.71%-13K | --0 | 81.71%-32K | 27.32%-298K | -128.26%-105K | 95.24%-7K | 94.50%-11K | -929.41%-175K |
| Net investment purchase and sale | 225.70%67.06M | 342.84%15.46M | 152.37%23.36M | 209.19%17.82M | -25.21%10.43M | -968.46%-53.35M | -295.01%-6.37M | -450.04%-44.61M | 28.21%-16.32M | -38.26%13.94M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 224.89%67M | 338.64%15.44M | 152.33%23.35M | 209.12%17.82M | -24.50%10.39M | -892.89%-53.65M | -301.06%-6.47M | -440.33%-44.62M | 28.78%-16.33M | -38.99%13.77M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -90.95%11.4M | -97.94%258K | -84.91%10.52M | -98.06%458K | -99.21%159K | 73.06%125.97M | 12.52M | 1,553.97%69.72M | -65.40%23.64M | 8,273.33%20.1M |
| Net issuance payments of debt | --0 | --0 | --0 | --0 | --0 | 887.65%40M | --12.5M | --0 | --7.5M | --20M |
| Net common stock issuance | -87.72%10.52M | 4,150.00%81K | -84.99%10.44M | ---- | ---- | 52.57%85.65M | ---2K | 165,723.81%69.56M | ---- | ---- |
| Proceeds from stock option exercised by employees | 172.36%877K | 883.33%177K | -45.75%83K | 732.73%458K | 65.63%159K | -97.44%322K | --18K | -26.09%153K | -99.55%55K | -60.00%96K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -90.95%11.4M | -97.94%258K | -84.91%10.52M | -98.06%458K | -99.21%159K | 73.06%125.97M | --12.52M | 1,553.97%69.72M | -65.40%23.64M | 8,273.33%20.1M |
| Net cash flow | ||||||||||
| Beginning cash position | 4.90%34.9M | -47.28%24.89M | -62.23%15.54M | -57.61%20.93M | 4.90%34.9M | 40.55%33.27M | 6.32%47.21M | -34.65%41.16M | 52.89%49.38M | 40.55%33.27M |
| Current changes in cash | -919.84%-13.51M | 71.95%-3.49M | 49.92%9.34M | 34.60%-5.38M | -186.89%-13.98M | -82.88%1.65M | -11.26%-12.44M | 133.58%6.23M | -126.80%-8.23M | 86.18%16.09M |
| Effect of exchange rate changes | 122.22%4K | -102.99%-4K | 99.45%-1K | -109.09%-1K | -47.37%10K | 28.00%-18K | 152.83%134K | -810.00%-182K | 125.58%11K | 226.67%19K |
| End cash Position | -38.70%21.39M | -38.70%21.39M | -47.28%24.89M | -62.23%15.54M | -57.61%20.93M | 4.90%34.9M | 4.90%34.9M | 6.32%47.21M | -34.65%41.16M | 52.89%49.38M |
| Free cash flow | -29.58%-91.97M | -3.30%-19.21M | -30.02%-24.54M | -52.05%-23.66M | -36.88%-24.57M | -22.01%-70.97M | -28.70%-18.59M | -28.74%-18.88M | -4.51%-15.56M | -26.59%-17.95M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |
Market Insights
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
Discussing
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma
Moo Live
Mar 20 02:25
FOMC Press Conference, March 19, 2025